8-KFiled Jul 28, 8:00 PM ET

Core Laboratories Reports Q2 2026 Results; Declares $0.01 Dividend

$CLB · Core Laboratories Inc. /DE/

Research Summary

AI-generated summary of this SEC filing

Updated

Core Laboratories Reports Q2 2026 Results; Declares $0.01 Dividend

What Happened

  • Core Laboratories Inc. (CLB) issued a press release on July 29, 2026 announcing its financial results for the second quarter of 2026 and a quarterly cash dividend. The press release is attached to the Form 8‑K as Exhibit 99.1. The 8‑K was signed by CFO Christopher S. Hill on July 29, 2026.
  • The filing does not embed detailed financial line items in the 8‑K text; the company’s Q2 2026 results are presented in the attached press release.

Key Details

  • Press release date: July 29, 2026 (Exhibit 99.1 to the Form 8‑K).
  • Dividend declared: $0.01 per share of common stock.
  • Dividend record date: August 10, 2026; payable date: August 31, 2026.
  • The press release and related information are furnished under Regulation FD and are not being “filed” for purposes of Section 18 of the Exchange Act.

Why It Matters

  • Earnings/quarterly results: The company has publicly reported its Q2 2026 results via press release; investors should review Exhibit 99.1 for revenue, profit, and other performance metrics that will affect valuation and trading decisions.
  • Dividend: A $0.01 per-share cash dividend is a formal distribution decision—investors who hold shares by the August 10, 2026 record date are eligible for payment on August 31, 2026. The amount is modest, so its impact on yield and cash returns will be small for most shareholders.
  • Next steps for investors: Read the attached press release for full financial details and management commentary, and consider the results in the context of prior quarters and guidance when assessing Core Laboratories’ financial health and outlook.